Literature DB >> 30855638

Overview of Cost-effectiveness Analysis.

Gillian D Sanders1,2,3, Matthew L Maciejewski1,4,5, Anirban Basu6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30855638     DOI： 10.1001/jama.2019.1265

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

Review 1.  Biomarkers for Parkinson's Disease: How Good Are They?

Authors:  Tianbai Li; Weidong Le
Journal:  Neurosci Bull       Date:  2019-10-23       Impact factor: 5.203

2.  Risk Scores to Improve Quality and Realize Health Economic Gains in Perioperative Care.

Authors:  Karsten Bartels; Robert L Lobato; Cathy J Bradley
Journal:  Anesth Analg       Date:  2021-09-01       Impact factor: 6.627

3.  Early analysis shows that endoscopic flexor hallucis longus transfer has a promising cost-effectiveness profile in the treatment of acute Achilles tendon ruptures.

Authors:  Pedro Diniz; André Soares Ferreira; Lígia Figueiredo; Jorge Pablo Batista; Nasef Abdelatif; Hélder Pereira; Gino M M J Kerkhoffs; Stan N Finkelstein; Frederico Castelo Ferreira
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-09-23       Impact factor: 4.114

4.  Health Preference Measures in Patients with Obstructive Sleep Apnea Syndrome Undergoing Continuous Positive Airway Pressure Therapy: Data from a Randomized Trial.

Authors:  Fabienne L Huber; Michael Furian; Malcolm Kohler; Tsogyal D Latshang; Yvonne Nussbaumer-Ochsner; Alexander Turk; Otto D Schoch; Irene Laube; Robert Thurnheer; Konrad E Bloch
Journal:  Respiration       Date:  2021-02-04       Impact factor: 3.580

5.  RACE-IT - Rapid Acute Coronary Syndrome Exclusion using the Beckman Coulter Access high-sensitivity cardiac troponin I: A stepped-wedge cluster randomized trial.

Authors:  Joseph Miller; Bernard Cook; Gulmohar Singh-Kucukarslan; Amy Tang; Shooshan Danagoulian; Gerard Heath; Ziad Khalifa; Phillip Levy; Simon A Mahler; Nicholas Mills; James McCord
Journal:  Contemp Clin Trials Commun       Date:  2021-04-23

6.  Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States.

Authors:  Anirban Basu; Varun J Gandhay
Journal:  Value Health       Date:  2021-03-08       Impact factor: 5.725

7.  Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.

Authors:  Akira Yuasa; Naohiro Yonemoto; Michael LoPresti; Shunya Ikeda
Journal:  Pharmacoeconomics       Date:  2020-11-24       Impact factor: 4.981

8.  Cost-effectiveness of Physical Therapy vs Intra-articular Glucocorticoid Injection for Knee Osteoarthritis: A Secondary Analysis From a Randomized Clinical Trial.

Authors:  Daniel I Rhon; Minchul Kim; Carl V Asche; Stephen C Allison; Chris S Allen; Gail D Deyle
Journal:  JAMA Netw Open       Date:  2022-01-04

9.  Cost-effectiveness of a telehealth intervention for in-home dementia care support: Findings from the FamTechCare clinical trial.

Authors:  Clarissa A Shaw; Kristine N Williams; Robert H Lee; Carissa K Coleman
Journal:  Res Nurs Health       Date:  2020-10-19       Impact factor: 2.228

10.  Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study.

Authors:  Hsi-Lan Huang; Chi Yan Leung; Eiko Saito; Kota Katanoda; Chin Hur; Chung Yin Kong; Shuhei Nomura; Kenji Shibuya
Journal:  BMC Med       Date:  2020-09-14       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.